Literature DB >> 17181654

Incidence and risk factors for the development of lung tumors after liver transplantation.

Carlos Jiménez1, Alejandro Manrique, Elia Marqués, Patricia Ortega, Patricia Ortegz, Carmelo Loinaz, Ramón Gómez, Juan C Meneu, Manuel Abradelo, Almudena Moreno, Angel López, Enrique Moreno.   

Abstract

Tobacco and immunosuppression are risk factors for developing upper aerodigestive and lung tumors after transplantation. This study comprises 701 adult recipients who survived more than 2 months after transplant: 276 patients underwent orthotopic liver transplantation (OLT) for alcoholic cirrhosis (AC) and 425 for nonalcoholic disease. The aim is to analyze the incidence, clinical characteristics, risk factors, and outcome of patients who develop lung malignancies after OLT. Incidence of lung cancer was 2.1% (15 patients): 4.3% (12 patients) in the alcoholic group and 0.7% (three patients) in the nonalcoholic group (P < 0.001). Mean time from OLT to tumor diagnosis was 86 months. Thirteen patients were smokers; 12 patients were heavy drinkers; and 11 were drinkers and smokers. Squamous cell carcinoma was diagnosed in nine patients, large cell carcinoma in three, adenocarcinoma in two, and broncoalveolar in one. Tumor staging: 10 patients at stage IV; three at stage IIIB; and two at stage IIB. Tumor resection was performed in one patient, and three also received chemotherapy. Mean survival after tumor diagnosis was 5.4 months. There is a higher risk of lung cancer in smoker patients who have undergone OLT for AC, and have a very poor prognosis because tumors are diagnosed at advanced stages.

Entities:  

Mesh:

Year:  2007        PMID: 17181654     DOI: 10.1111/j.1432-2277.2006.00397.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  13 in total

1.  Smoking and Liver Disease.

Authors:  Stephanie M Rutledge; Amon Asgharpour
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-12

2.  Alcohol and tobacco misuse: Reducing aerodigestive cancer risk.

Authors:  Gavin Wright; Marsha Y Morgan
Journal:  World J Hepatol       Date:  2013-08-27

Review 3.  Long-term survival after liver transplantation for alcoholic liver disease.

Authors:  Paula Iruzubieta; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 4.  Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis.

Authors:  Carlos Jiménez-Romero; Iago Justo-Alonso; Félix Cambra-Molero; Jorge Calvo-Pulido; Álvaro García-Sesma; Manuel Abradelo-Usera; Oscar Caso-Maestro; Alejandro Manrique-Municio
Journal:  World J Hepatol       Date:  2015-05-08

5.  Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years.

Authors:  Carlos Jiménez-Romero; Marta Clemares-Lama; Alejandro Manrique-Municio; Alvaro García-Sesma; Jorge Calvo-Pulido; Enrique Moreno-González
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

Review 6.  Challenges in transplantation for alcoholic liver disease.

Authors:  Gabriela A Berlakovich
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 7.  Neoplastic disease after liver transplantation: Focus on de novo neoplasms.

Authors:  Patrizia Burra; Kryssia I Rodriguez-Castro
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

8.  Impact of cigarette smoking on early complications after liver transplantation: A single-center experience and a meta-analysis.

Authors:  Qingshan Li; Yue Wang; Tao Ma; Xuemin Liu; Bo Wang; Zheng Wu; Yi Lv; Rongqian Wu
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

9.  Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men.

Authors:  Umberto Maggi; Dario Consonni; Matteo Angelo Manini; Stefano Gatti; Francesco Cuccaro; Francesca Donato; Grazia Conte; Pier Alberto Bertazzi; Giorgio Rossi
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

Review 10.  Tumor-induced CD8+ T-cell dysfunction in lung cancer patients.

Authors:  Heriberto Prado-Garcia; Susana Romero-Garcia; Dolores Aguilar-Cazares; Manuel Meneses-Flores; Jose Sullivan Lopez-Gonzalez
Journal:  Clin Dev Immunol       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.